Page last updated: 2024-10-20

pyrazinoic acid and Carcinoma

pyrazinoic acid has been researched along with Carcinoma in 1 studies

pyrazinoic acid: active metabolite of pyrazinamide; structure
pyrazine-2-carboxylic acid : The parent compound of the class of pyrazinecarboxylic acids, that is pyrazine bearing a single carboxy substituent. The active metabolite of the antitubercular drug pyrazinamide.

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sahdev, AK1
Raj, V1
Singh, AK1
Rai, A1
Keshari, AK1
De, A1
Samanta, A1
Kumar, U1
Rawat, A1
Kumar, D1
Nath, S1
Prakash, A1
Saha, S1

Other Studies

1 other study available for pyrazinoic acid and Carcinoma

ArticleYear
Ameliorative effects of pyrazinoic acid against oxidative and metabolic stress manifested in rats with dimethylhydrazine induced colonic carcinoma.
    Cancer biology & therapy, 2017, 05-04, Volume: 18, Issue:5

    Topics: Animals; Apoptosis; Carcinoma; Cell Proliferation; Colonic Neoplasms; Dimethylhydrazines; Gene Expre

2017